Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Woiwode Thomas
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-04-29
Purchase
2022-05-03
5:49 pm
Tempest Therapeutics Inc.TPSTWoiwode Thomas
Director
10% Owner
2,118,644$2.36$5,000,0004,295,055
(Indirect)
View
2020-12-30
Purchase
2021-01-04
6:02 pm
Gritstone Oncology Inc.GRTSWoiwode Thomas
Director
1,347,709$3.71$5,000,0004,450,638
(Indirect)
View
2020-10-20
Purchase
2020-10-20
5:00 pm
Aligos Therapeutics Inc.ALGSWoiwode Thomas
Director
200,000$15$3,000,000862,444
(Indirect)
View
2020-03-03
Purchase
2020-03-03
7:03 pm
Passage BIO Inc.PASGVersant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Woiwode Thomas
10% Owner
225,000$18$4,050,0004,959,769
(Indirect
Direct)
View
2020-03-03
Purchase
2020-03-03
6:57 pm
Passage BIO Inc.PASGWoiwode Thomas
Director
10% Owner
225,000$18$4,050,000933,352
(Indirect)
View
2018-05-15
Sale
2018-05-17
5:11 pm
CRISPR Therapeutics AGCRSPWoiwode Thomas
Director
44,000$57.99$2,551,440645,643
(Indirect
Direct)
View
2018-05-07
Sale
2018-05-09
5:15 pm
CRISPR Therapeutics AGCRSPWoiwode Thomas
Director
121,362$50.39$6,115,87396,359
(Indirect
Direct)
View
2018-04-30
Sale
2018-05-02
6:00 pm
CRISPR Therapeutics AGCRSPWoiwode Thomas
Director
30,566$50.29$1,537,138106,018
(Indirect
Direct)
View
2018-04-26
Sale
2018-04-30
8:57 pm
CRISPR Therapeutics AGCRSPWoiwode Thomas
Director
222,258$50.11$11,136,437100,780
(Indirect)
View
2018-04-24
Sale
2018-04-26
5:01 pm
CRISPR Therapeutics AGCRSPWoiwode Thomas
Director
22,841$50.99$1,164,655115,645
(Indirect)
View
2018-04-20
Sale
2018-04-24
7:42 pm
CRISPR Therapeutics AGCRSPWoiwode Thomas
Director
101,994$50.68$5,168,901812,614
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-06-23
Option Award
2022-06-27
4:14 pm
N/A
2032-06-23
Aligos Therapeutics Inc.ALGSWoiwode Thomas
Director
15,000$015,000
(Direct)
View
2022-06-17
Option Award
2022-06-22
4:13 pm
N/A
2032-06-16
Tempest Therapeutics Inc.TPSTWoiwode Thomas
Director
3,500$03,500
(Direct)
View
2022-05-26
Option Award
2022-05-31
4:33 pm
N/A
2032-05-25
Passage BIO Inc.PASGWoiwode Thomas
Director
10% Owner
24,000$024,000
(Direct)
View
2021-07-01(A)
Option Award
2021-09-20
8:13 pm
N/A
2031-06-30
Tempest Therapeutics Inc.TPSTWoiwode Thomas
Director
6,635$06,635
(Direct)
View
2021-08-25
Other
2021-08-27
5:49 pm
N/A
N/A
Gritstone bio Inc.GRTSWoiwode Thomas
Director
458,152$03,574,489
(Indirect)
View
2021-07-01
Option Award
2021-07-06
6:01 pm
N/A
2031-06-30
Tempest Therapeutics Inc.TPSTWoiwode Thomas
Director
10% Owner
6,635$06,635
(Direct)
View
2021-06-25
Option Award
2021-06-29
9:54 pm
N/A
N/A
Millendo Therapeutics Inc.TPSTWoiwode Thomas
Director
10% Owner
2,176,411$07,377
(Indirect)
View
2021-06-17
Option Award
2021-06-17
5:14 pm
N/A
2031-06-17
Aligos Therapeutics Inc.ALGSWoiwode Thomas
Director
15,000$015,000
(Direct)
View
2021-06-11
Other
2021-06-15
4:43 pm
N/A
N/A
Aligos Therapeutics Inc.ALGSWoiwode Thomas
Director
506,307$01,391,305
(Indirect)
View
2021-05-27
Option Award
2021-05-28
6:06 pm
N/A
2031-05-26
Passage BIO Inc.PASGWoiwode Thomas
Director
10% Owner
16,918$016,918
(Direct)
View
2021-05-12
Option Award
2021-05-14
8:05 pm
N/A
2031-05-11
Adverum Biotechnologies Inc.ADVMWoiwode Thomas
Director
40,000$040,000
(Direct)
View
2021-04-26
Other
2021-04-28
5:00 pm
N/A
N/A
Aligos Therapeutics Inc.ALGSWoiwode Thomas
Director
506,310$01,389,085
(Indirect)
View
2020-12-14
Other
2020-12-16
5:10 pm
N/A
N/A
Adverum Biotechnologies Inc.ADVMWoiwode Thomas
Director
12,783$031,605
(Direct)
View
2020-10-20
Conversion
2020-10-20
5:00 pm
N/A
N/A
Aligos Therapeutics Inc.ALGSWoiwode Thomas
Director
3,092,339$0862,444
(Indirect)
View
2020-10-15
Ownership
2020-10-15
5:17 pm
N/A
N/A
Aligos Therapeutics Inc.ALGSWoiwode Thomas
Director
0$03,092,339
(Indirect)
View
2020-06-23
Option Award
2020-06-25
5:45 pm
N/A
2030-06-22
Adverum Biotechnologies Inc.ADVMWoiwode Thomas
Director
30,000$030,000
(Direct)
View
2020-06-18
Option Award
2020-06-22
5:40 pm
N/A
2030-06-18
Gritstone Oncology Inc.GRTSWoiwode Thomas
Director
10% Owner
12,500$012,500
(Direct)
View
2020-03-03
Conversion
2020-03-03
7:03 pm
N/A
N/A
Passage BIO Inc.PASGVersant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Woiwode Thomas
10% Owner
4,734,769$04,959,769
(Direct)
View
2020-03-03
Conversion
2020-03-03
6:57 pm
N/A
N/A
Passage BIO Inc.PASGWoiwode Thomas
Director
10% Owner
4,734,769$0933,352
(Indirect)
View
2020-02-27
Option Award
2020-03-02
6:01 pm
N/A
2030-02-27
Passage BIO Inc.PASGWoiwode Thomas
Director
10% Owner
33,836$033,836
(Direct)
View
2020-02-27
Ownership
2020-02-27
8:07 pm
N/A
N/A
Passage BIO Inc.PASGVersant Venture Capital VI L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Versant Vantage I L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Woiwode Thomas
10% Owner
0$04,734,769
(Direct)
View
2020-02-27
Ownership
2020-02-27
7:57 pm
N/A
N/A
Passage BIO Inc.PASGWoiwode Thomas
Director
10% Owner
0$04,734,769
(Indirect)
View
2019-07-31
Option Award
2019-08-02
4:25 pm
N/A
2029-07-30
Adverum Biotechnologies Inc.ADVMWoiwode Thomas
Director
45,000$045,000
(Direct)
View
2019-06-19
Option Award
2019-06-20
4:17 pm
N/A
2029-06-19
Gritstone Oncology Inc.GRTSWoiwode Thomas
Director
10% Owner
8,570$08,570
(Direct)
View
2018-10-02
Conversion
2018-10-02
5:29 pm
N/A
N/A
Gritstone Oncology Inc.GRTSWoiwode Thomas
Director
10% Owner
6,205,858$03,102,929
(Indirect)
View
2018-09-27
Ownership
2018-09-27
5:26 pm
N/A
N/A
Gritstone Oncology Inc.GRTSWoiwode Thomas
Director
10% Owner
0$03,102,929
(Indirect)
View
2018-06-15
Option Award
2018-06-15
9:39 pm
N/A
2028-06-15
CRISPR Therapeutics AGCRSPWoiwode Thomas
Director
30,000$030,000
(Indirect)
View
2018-05-31
Option Award
2018-06-15
4:27 pm
N/A
2028-05-30
Adverum Biotechnologies Inc.ADVMWoiwode Thomas
Director
35,000$035,000
(Direct)
View
2018-04-20
Other
2018-04-24
7:42 pm
N/A
N/A
CRISPR Therapeutics AGCRSPWoiwode Thomas
Director
595,241$0812,614
(Indirect)
View
(A) Indicate amendment filing.